Pharmatica

In this special Scientific Council Spotlight episode of The Discovery Loop podcast, host Shubhangi Dua, Journalist, Podcast Producer and Podcast Host at Pharmatica.io, sits down with Deepankar Nayak, the CEO of Deep Longevity. Nayak also serves on Pharmatica’s Scientific Council.

Could Biological Ageing Be the Next Big Shift in Drug Discovery?

“The pharma industry is beginning to look at biological age as a surrogate endpoint to improve clinical trials."

In the recent episode of The Clinical Compass podcast, host Shubhangi Dua, Podcast Producer and B2B Journalist, is joined by Dr Amber Hill, Founder and CEO of Research Grid. They talk about how pharmaceutical companies and their leaders should approach the use of AI in clinical trials.

In the recent episode of The Discovery Loop podcast, host Shubhangi Dua, Podcast Producer and B2B Journalist at Pharmatica.io, sat down with Diana Andrade, Founder & Managing Director at RD Privacy and Data Protection Officer (DPO) for Biopharma and Life Sciences. They talk about the current state of data protection regulations and how enterprises can innovate responsibly.

In the recent episode of The Chain Reaction podcast, Nour AlSaleh, Founder and CEO of Veragence Pharma Consultancy, sat down with host Shubhangi Dua, Podcast Producer and B2B Journalist at Pharmatica.io and EM360Tech. AlSaleh shares her expertise on maintaining data integrity in this new era of AI and changing policies.

Kate O’Reilly, President & Chair of the Healthcare Businesswomen’s Association (HBA) Dublin-Ireland Chapter & Healthcare Transformation Partner at Roche, discusses AI in pharma, patient engagement, and the future of healthcare innovation.

In the recent episode of the Digital Pulse podcast, host Shubhangi Dua, Podcast Producer and B2B Journalist, sat down with Lara Masad, an AI and Data Innovation independent consultant, to clarify the key distinctions in AI and machine learning models. Furthermore, Masad explains how pharmaceutical companies benefit from using AI models.

Trisha Pillay speaks with Judit Mora, CEO of Nuumad, on Digital Pulse discussing pharmacy innovation, market access barriers, and new models for faster patient access to healthcare.

Trisha Pillay speaks with Dineshree Naiker, co-founder of Umsebe Healthcare, on Chain Reaction discussing regulatory leadership, pharmaceutical supply chains, and improving patient access to medicines.

Exclusive Pharmatica Content

Explore expert-led podcasts, pharmaceutical intelligence, life sciences insights and research-driven analysis from leading industry voices. Pharmatica delivers trusted biotech news, drug development trends and commercial intelligence for professionals across the pharmaceutical sector.

Nicole Dale

Digital Twins in Clinical Trials: Simulating Success Before Enrolment

Digital twins in clinical trials simulate patient outcomes to reduce risk and accelerate timelines. Learn how sponsors use them for predictive trial design.

Nicole Dale

Precision Logistics to Speed Up Clinical Trials

Precision logistics in clinical trials is transforming global study execution through real-time tracking, cold-chain management, and advanced operational visibility.

Nicole Dale

Designing Decentralised Clinical Trials for Patient Diversity

A graphic banner for "Pharmatica" on DCT and Patient Diversity displaying a healthcare clinical trial theme. Left & Center: A realistic photo of an older Black woman sitting in a medical office, smiling and conversing with a female healthcare provider who is wearing a white lab coat and stethoscope.

Data shows that most DCT approaches significantly improve patient diversity. This analysis examines what the evidence means for clinical trial design strategy.

Nicole Dale

Select the Right Data Collection Method for Real-World Evidence

Choosing the wrong RWE data source undermines your regulatory strategy. This framework helps pharma leaders select the right real-world data collection method based on your programme’s research question.

Nicole Dale

Decentralised Clinical Trials: Balance Innovation and Integrity

Decentralised clinical trials expand access and reduce patient burden. Learn how sponsors balance innovation in DCT design, data integrity, and regulatory compliance.

Nicole Dale

Preclinical vs Clinical Research Strategy for Drug Development

Explore the critical differences between preclinical vs clinical research, and how closing the translation gap can reduce drug development attrition and improve R&D decision-making.

Content type

Topic

Articles, expert interviews, and insights from life sciences leaders

Could Biological Ageing Be the Next Big Shift in Drug Discovery?

Digital Twins in Clinical Trials: Simulating Success Before Enrolment

Precision Logistics to Speed Up Clinical Trials

Designing Decentralised Clinical Trials for Patient Diversity

Select the Right Data Collection Method for Real-World Evidence

Decentralised Clinical Trials: Balance Innovation and Integrity

Preclinical vs Clinical Research Strategy for Drug Development